Advertisement
Nutrien (TSE:NTR) Full Year 2024 Results
Key Financial Results
- Revenue: US$25.0b (down 11% from FY 2023).
- Net income: US$674.0m (down 46% from FY 2023).
- Profit margin: 2.7% (down from 4.5% in FY 2023).
- EPS: US$1.36 (down from US$2.53 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Nutrien Revenues Disappoint
Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) was mostly in line with analyst estimates.
The primary driver behind last 12 months revenue was the Retail segment contributing a total revenue of US$17.8b (71% of total revenue). Notably, cost of sales worth US$17.5b amounted to 70% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to US$3.44b (50% of total expenses). Explore how NTR's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Canada.
Performance of the Canadian Chemicals industry.
The company's shares are up 3.7% from a week ago.
Risk Analysis
We should say that we've discovered 4 warning signs for Nutrien that you should be aware of before investing here.
Valuation is complex, but we're here to simplify it.
Discover if Nutrien might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSX:NTR
Good value with proven track record.
Similar Companies
Market Insights
Advertisement
Weekly Picks
AL
AlexLovell on Rocket Lab ·
Early mover in a fast growing industry. Likely to experience share price volatility as they scale
Fair Value:US$16.25380.9% overvalued
69 followersusers have followed this narrative
1 commentusers have commented on this narrative
18 likesusers have liked this narrative
AG
Agricola on Excellon Resources ·
A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).
Fair Value:CA$31.898.4% undervalued
69 followersusers have followed this narrative
10 commentsusers have commented on this narrative
20 likesusers have liked this narrative
FU
FundamentallySarcastic on Credit Corp Group ·
Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08
Fair Value:AU$12.6411.0% overvalued
11 followersusers have followed this narrative
1 commentusers have commented on this narrative
0 likesusers have liked this narrative
Recently Updated Narratives
BA
bactrian on Novo Nordisk ·
A Quality Compounder Marked Down on Overblown Fears
Fair Value:US$9542.0% undervalued
95 followersusers have followed this narrative
8 commentsusers have commented on this narrative
0 likesusers have liked this narrative
YI
yiannisz on Etsy ·
Etsy Stock: Defending Differentiation in a World of Infinite Marketplaces
Fair Value:US$64.459.1% undervalued
4 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
YI
yiannisz on Align Technology ·
Align Technology Stock: Premium Orthodontics in a Cost-Sensitive World
Fair Value:US$154.623.6% overvalued
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Popular Narratives
AG
Agricola on Excellon Resources ·
A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).
Fair Value:CA$31.898.4% undervalued
69 followersusers have followed this narrative
10 commentsusers have commented on this narrative
20 likesusers have liked this narrative
AL
AlexLovell on Rocket Lab ·
Early mover in a fast growing industry. Likely to experience share price volatility as they scale
Fair Value:US$16.25380.9% overvalued
69 followersusers have followed this narrative
1 commentusers have commented on this narrative
18 likesusers have liked this narrative
AN
AnalystConsensusTarget on NVIDIA ·
NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
Fair Value:US$253.0225.6% undervalued
1020 followersusers have followed this narrative
6 commentsusers have commented on this narrative
28 likesusers have liked this narrative
Trending Discussion
ST
StevenM on Excellon Resources ·
Interesting analysis, but the price trajectory assumed for the baseline metals is problematic. These assumptions form the foundation for the entire case, and when compared against historical pricing, don’t appear to be grounded in any reasonable precedent. Even accounting for past commodity super-cycles, inflationary periods, or supply constraints, the forecasted pricing for gold, silver, zinc, and lead are well outside what history would suggest is plausible over comparable timeframes. That creates a fragile premise as the conclusions are driven by aggressive inputs rather than underlying market behavior that is realistic. The analysis would be materially stronger if the price assumptions were anchored to historical ranges and prior cycle peaks, with explicit rationale where the model intentionally departs from those patterns. As it stands, the trajectory feels more aspirational than analytical.
1
|1